Skip to Content

Lenzilumab

https://www.medicalbillingandcodingcertification.net/web/image/product.template/261311/image_1920?unique=778ea14
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies[1][2].

2,001.20 € 2001.2 EUR 2,001.20 €

2,001.20 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days